Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-06-11

Clinical Trial Update: Evaluation of the Level of Expression of CD45RC on T Lymphocytes as a Predictive Biomarker of Acute Rejection After Renal Transplantation [NA]

View source ↗

Summary

This ongoing study evaluates whether the level of CD45RC expression on T lymphocytes can serve as a predictive biomarker for acute rejection after kidney transp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Hospital, Angers | Conditions: End-stage Renal Disease | NA | Status: RECRUITING